Differential Effects of ‘Vaping’ on Lipid and Glucose Profiles and Liver Metabolic Markers in Obese Versus Non-obese Mice

Tobacco smoking increases the risk of metabolic disorders due to the combination of harmful chemicals, whereas pure nicotine can improve glucose tolerance. E-cigarette vapour contains nicotine and some of the harmful chemicals found in cigarette smoke at lower levels. To investigate how e-vapour aff...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hui Chen, Gerard Li, Yik Lung Chan, Hui Emma Zhang, Mark D. Gorrell, Carol A. Pollock, Sonia Saad, Brian G. Oliver
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/6daccfcfd4374bfc99055b30083d175c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6daccfcfd4374bfc99055b30083d175c
record_format dspace
spelling oai:doaj.org-article:6daccfcfd4374bfc99055b30083d175c2021-11-04T06:20:37ZDifferential Effects of ‘Vaping’ on Lipid and Glucose Profiles and Liver Metabolic Markers in Obese Versus Non-obese Mice1664-042X10.3389/fphys.2021.755124https://doaj.org/article/6daccfcfd4374bfc99055b30083d175c2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fphys.2021.755124/fullhttps://doaj.org/toc/1664-042XTobacco smoking increases the risk of metabolic disorders due to the combination of harmful chemicals, whereas pure nicotine can improve glucose tolerance. E-cigarette vapour contains nicotine and some of the harmful chemicals found in cigarette smoke at lower levels. To investigate how e-vapour affects metabolic profiles, male Balb/c mice were exposed to a high-fat diet (HFD, 43% fat, 20kJ/g) for 16weeks, and e-vapour in the last 6weeks. HFD alone doubled fat mass and caused dyslipidaemia and glucose intolerance. E-vapour reduced fat mass in HFD-fed mice; only nicotine-containing e-vapour improved glucose tolerance. In chow-fed mice, e-vapour increased lipid content in both blood and liver. Changes in liver metabolic markers may be adaptive responses rather than causal. Future studies can investigate how e-vapour differentially affects metabolic profiles with different diets.Hui ChenGerard LiYik Lung ChanHui Emma ZhangMark D. GorrellCarol A. PollockSonia SaadBrian G. OliverBrian G. OliverFrontiers Media S.A.articleliverabdominal obesityfree fatty acidtriglyceridesglucose tolerancePhysiologyQP1-981ENFrontiers in Physiology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic liver
abdominal obesity
free fatty acid
triglycerides
glucose tolerance
Physiology
QP1-981
spellingShingle liver
abdominal obesity
free fatty acid
triglycerides
glucose tolerance
Physiology
QP1-981
Hui Chen
Gerard Li
Yik Lung Chan
Hui Emma Zhang
Mark D. Gorrell
Carol A. Pollock
Sonia Saad
Brian G. Oliver
Brian G. Oliver
Differential Effects of ‘Vaping’ on Lipid and Glucose Profiles and Liver Metabolic Markers in Obese Versus Non-obese Mice
description Tobacco smoking increases the risk of metabolic disorders due to the combination of harmful chemicals, whereas pure nicotine can improve glucose tolerance. E-cigarette vapour contains nicotine and some of the harmful chemicals found in cigarette smoke at lower levels. To investigate how e-vapour affects metabolic profiles, male Balb/c mice were exposed to a high-fat diet (HFD, 43% fat, 20kJ/g) for 16weeks, and e-vapour in the last 6weeks. HFD alone doubled fat mass and caused dyslipidaemia and glucose intolerance. E-vapour reduced fat mass in HFD-fed mice; only nicotine-containing e-vapour improved glucose tolerance. In chow-fed mice, e-vapour increased lipid content in both blood and liver. Changes in liver metabolic markers may be adaptive responses rather than causal. Future studies can investigate how e-vapour differentially affects metabolic profiles with different diets.
format article
author Hui Chen
Gerard Li
Yik Lung Chan
Hui Emma Zhang
Mark D. Gorrell
Carol A. Pollock
Sonia Saad
Brian G. Oliver
Brian G. Oliver
author_facet Hui Chen
Gerard Li
Yik Lung Chan
Hui Emma Zhang
Mark D. Gorrell
Carol A. Pollock
Sonia Saad
Brian G. Oliver
Brian G. Oliver
author_sort Hui Chen
title Differential Effects of ‘Vaping’ on Lipid and Glucose Profiles and Liver Metabolic Markers in Obese Versus Non-obese Mice
title_short Differential Effects of ‘Vaping’ on Lipid and Glucose Profiles and Liver Metabolic Markers in Obese Versus Non-obese Mice
title_full Differential Effects of ‘Vaping’ on Lipid and Glucose Profiles and Liver Metabolic Markers in Obese Versus Non-obese Mice
title_fullStr Differential Effects of ‘Vaping’ on Lipid and Glucose Profiles and Liver Metabolic Markers in Obese Versus Non-obese Mice
title_full_unstemmed Differential Effects of ‘Vaping’ on Lipid and Glucose Profiles and Liver Metabolic Markers in Obese Versus Non-obese Mice
title_sort differential effects of ‘vaping’ on lipid and glucose profiles and liver metabolic markers in obese versus non-obese mice
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/6daccfcfd4374bfc99055b30083d175c
work_keys_str_mv AT huichen differentialeffectsofvapingonlipidandglucoseprofilesandlivermetabolicmarkersinobeseversusnonobesemice
AT gerardli differentialeffectsofvapingonlipidandglucoseprofilesandlivermetabolicmarkersinobeseversusnonobesemice
AT yiklungchan differentialeffectsofvapingonlipidandglucoseprofilesandlivermetabolicmarkersinobeseversusnonobesemice
AT huiemmazhang differentialeffectsofvapingonlipidandglucoseprofilesandlivermetabolicmarkersinobeseversusnonobesemice
AT markdgorrell differentialeffectsofvapingonlipidandglucoseprofilesandlivermetabolicmarkersinobeseversusnonobesemice
AT carolapollock differentialeffectsofvapingonlipidandglucoseprofilesandlivermetabolicmarkersinobeseversusnonobesemice
AT soniasaad differentialeffectsofvapingonlipidandglucoseprofilesandlivermetabolicmarkersinobeseversusnonobesemice
AT briangoliver differentialeffectsofvapingonlipidandglucoseprofilesandlivermetabolicmarkersinobeseversusnonobesemice
AT briangoliver differentialeffectsofvapingonlipidandglucoseprofilesandlivermetabolicmarkersinobeseversusnonobesemice
_version_ 1718445094532546560